{"id":"W1911252495","doi":"","title":"A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mitoxantrone; Prostate cancer; Medicine; Chemotherapy; Internal medicine; Cancer; Urology; Phases of clinical research; Neutropenia; Gastroenterology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001697522,0.0003011966,0.0006309877,0.0003048606,0.00008571406,0.00002886455,0.00005334984,0.00003077072,0.000006518474],"category_scores_gemma":[0.00001151392,0.0001809123,0.00002760737,0.0004671463,0.0001444023,0.000214604,0.00002279757,0.0001306072,5.918799e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003542026,"about_ca_system_score_gemma":0.0001313255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001265561,"about_ca_topic_score_gemma":0.0009724486,"domain_scores_codex":[0.9979924,0.0001223446,0.0003439398,0.0004623775,0.0004696731,0.0006092933],"domain_scores_gemma":[0.9989721,0.00005181369,0.000168723,0.0003240501,0.0001307768,0.0003525672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05259023,0.02382417,0.7757743,0.00008251299,0.0008639221,0.001105294,0.00295534,0.00001002047,0.0004353984,0.000001005872,0.00001183879,0.142346],"study_design_scores_gemma":[0.1236971,0.03014826,0.8435711,0.00006530761,0.0004332439,0.00001349291,0.00121233,0.00005172591,0.0005527816,0.000002010116,0.00006371301,0.0001889528],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921134,0.001049584,7.135914e-7,0.0001335497,0.00002466974,0.006524312,0.00006361606,0.00003469675,0.00005542062],"genre_scores_gemma":[0.9962873,0.001274778,0.00006677428,0.0000177496,0.00001986981,0.001892807,0.00008037902,0.00004910431,0.0003112021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.142157,"threshold_uncertainty_score":0.7377391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03681151704988009,"score_gpt":0.3088887734766909,"score_spread":0.2720772564268108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}